General Info
Marcel Kloosterman, Managing Partner at Brightlands Venture Partners, focuses on investment in life sciences and cleantech. His previous investments include Hy2Care, Health Value Creation, FABPulous, and Q Chip. He typically invests in Series A and Series B funding rounds. Marcel’s investment check sizes range from â¬1 million to â¬6 million. He has a Ph.D. in organic chemistry from Leiden University and holds various board positions in portfolio companies.
Location: Netherlands
Country: Netherlands
Industries: Not available
Investment Regions: EU
Investment Stages: pre-seed, seed
angel-individual
EU
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: not-active
AI Reasoning: Searches found portfolio investments (Hy2Care, FABPulous, Q Chip) with latest documented investment activity in public sources dating back to 2019 and portfolio/impact reports mentioning investments up to 2023; no verifiable investment by Marcel Kloosterman within the past 12 months was found. The most recent verifiable portfolio financing mentioned was in Dec 2023 (Matisse finance round) which is more than 12 months prior to the reference date, so classify as not-active.
Angel activity thresholds:
Low Activity – Only known angel investments more than 12 months ago.
Active – Known angel investments between the last 12 and 6 months.
Very Active – Known angel investments in the last 6 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Marcel Kloosterman
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI